338 filings
Page 15 of 17
ARS
7dyr3aowk4l2p
4 May 12
Annual report to shareholders
12:00am
8-K
s2z ozxsa
3 May 12
Pacira Pharmaceuticals, Inc. Completes $27.5 Million Debt Refinancing
12:00am
DEF 14A
sx3nfht3z2
24 Apr 12
Definitive proxy
12:00am
424B5
7gq gavpjpo0e0ost
12 Apr 12
Prospectus supplement for primary offering
12:00am
FWP
ozdvpq8
12 Apr 12
Free writing prospectus
12:00am
8-K
lx5j8ups1vi5y68gg0bl
12 Apr 12
Pacira Pharmaceuticals, Inc. Prices Public Offering of Common Stock
12:00am
424B5
418 piak4tom
11 Apr 12
Prospectus supplement for primary offering
12:00am
EFFECT
wubdeu66w0azu44 cv
5 Apr 12
Notice of effectiveness
12:00am
S-3
m2i ix32sdj95r
27 Mar 12
Shelf registration
12:00am
8-K
vpi6rinxx
27 Mar 12
Results of Operations and Financial Condition
12:00am
8-K
9tb8csd
23 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
uqus uqn8y8cril
9 Jan 12
EXPAREL Expected to be Commercially Available in April 2012
12:00am
8-K
jk6y8krqyofkla8z9
6 Jan 12
Termination of a Material Definitive Agreement
12:00am
8-K
vqrkf
5 Jan 12
Departure of Directors or Certain Officers
12:00am
8-K
46a7e
9 Dec 11
Departure of Directors or Certain Officers
12:00am
424B4
fqm4mc stxqpe4313wf
16 Nov 11
Prospectus supplement with pricing info
12:00am
EFFECT
8hy63tmq
15 Nov 11
Notice of effectiveness
12:00am
S-1MEF
2v8ap16f9y ur8hacry
15 Nov 11
Registration of additional securities for an S-1
12:00am
CT ORDER
2q458a1p
14 Nov 11
Confidential treatment order
12:00am